Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
absent, alleviation, analyze, analyzed, antigen, ASH, BCX, bendamustine, Brother, composed, conjunction, Cooperation, debilitating, Deduct, delivered, Deputy, Dermatology, disallow, dispute, disputed, Duvic, EHS, Eisai, EU, euro, European, experimental, explored, extremely, Farm, formal, Frameworkissued, gather, Glaxo, hcl, HClfor, Hemisphere, improvement, inInternal, instrument, intramuscularly, irrevocable, Kildaire, Kline, landscape, Lastly, lost, Madeline, missing, moderate, needle, NonrefundableAdvance, Northern, Notwithstanding, oseltmivir, outcome, painful, PCT, peramivirIn, pk, plaque, poster, preliminary, rank, reader, renovation, resale, Road, shedding, symptom, synergistic, Targretin, tenant, timeframe, tradename, Treaty, unbilled, unchanged, uncomplicated, Union, unplanned, unregistered, viability, virologic, voluntarily, voluntary, warrant
Removed:
accelerated, accelerating, accept, account, accrue, acting, aggressive, agree, analyst, appointed, Avigen, Bachelor, background, banking, beneficially, biographical, Brazil, budget, capacity, care, career, Carl, CEO, CFA, challenging, Ciba, Colgate, commencing, community, concentrated, consent, consultant, contest, Controller, Cornell, cumulative, Darwin, decelerating, defer, dependence, deposited, derive, designing, Dillon, District, divided, DOV, duly, Electronic, Eli, England, escrow, exclusively, expert, expiring, faculty, familiar, family, Fellow, financed, formulating, founder, founding, fourth, Genaera, GeneMedicine, Genuine, GenVec, Harvard, heavy, hiring, history, holding, Hong, Horovitz, Immunicon, influence, integrity, intent, interferon, investor, Isaly, John, joined, joining, Joseph, Journal, Jr, Kong, law, leaving, Lexicon, Liaison, Lilly, line, listing, literacy, Manager, Marion, Medicaid, Medicare, Mehta, Michael, Motion, nation, NIH, NitroMed, offsetting, operated, optimization, organization, organizational, outsource, oversaw, Palatin, pathway, personal, preceding, predecessor, privately, produced, proliferating, Puerto, qualification, qualified, Randall, Randolph, recommendation, recovered, recruiting, referral, reform, relied, relinquished, removal, replication, resignation, resolution, restore, restrict, Revlon, ribavirin, Rico, RJR, Rockefeller, sabbatical, Secretary, security, selected, selecting, served, shareholder, Sherrill, size, Spencer, Squibb, staggered, stated, Steer, subsidiary, successor, supermajority, targeting, Techne, tender, Textbook, TransMolecular, Treasurer, Treasury, TRUBION, unit, venture, Vice, view, Weill, wholly, writing, Zola, Zycogen
Filing tables
Filing exhibits
- 10-K Annual report
- 10.1 EX-10.1 Annual Incentive Plan
- 10.2 EX-10.2 Executive Relocation Policy
- 10.3 EX-10.3 Amendment to Employment Letter Agreement
- 10.4 EX-10.4 Form of Notice of Grant Non-employee Director
- 10.5 EX-10.5 Form of Notice of Grant of Stock Option
- 10.6 EX-10.6 Amendment #3 to the Agreement
- 23 EX-23 Consent of Ernst & Young
- 31.1 EX-31.1 Certification of the Chief Executive Officer
- 31.2 EX-31.2 Certification of the Chief Financial Officer
- 32.1 EX-32.1 Section 906 Certification of the CEO
- 32.2 EX-32.2 Section 906 Certification of the CFO
Related press release
BCRX similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of BioCryst Pharmaceuticals, Inc. (the “Company”) on Form 10-K for the period ending December 31, 2007 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Stuart Grant, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
/s/ Stuart Grant
Stuart Grant
Chief Financial Officer
March 4, 2008
Stuart Grant
Chief Financial Officer
March 4, 2008
This certification is furnished with this Report on Form 10-K pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not, except to the extent required by such Act, be deemed filed by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the Company specifically incorporates it by reference.
107